RE:A combined GBM & NSCLC Phase 1b ?Hi Eoganacht...My literal interpretation of this statement would conclude that they intend to do a basket-type trial examining our ACT against two different cancer cohorts simultaneously. Such a trial would be a great jumpstart in validating our ACT's efficacy across multiple cancer types. However, considering the distinct differences in cancer types, behavior & location, my guess is it simply means that our ACT will be used against GBM & NSCLC in separate trials, either in succession or concomitantly...& more likely in succession. All imo. Good luck.